TriLink Receives $100,000 SBIR Grant | GenomeWeb

By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – TriLink BioTechnology said today it has received a $100,000 Phase I Small Business Innovation Research grant from the National Institutes of Health to develop a Hot Start approach for Ligase Chain Reaction.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.